Victims of a fungal meningitis outbreak traced to a tainted steroid produced by a Massachusetts compounding pharmacy will be compensated from a $100-million fund created as part of the legal settlement stemming from the 2012 incident. The settlement was filed this week in federal bankruptcy...
via L.A. Times - Science http://ift.tt/1kXQMyu
via L.A. Times - Science http://ift.tt/1kXQMyu
No comments:
Post a Comment